CAS NO: | 1009583-20-3 |
生物活性 | BMS-816336 is a novel, potent and orally bioavailable inhibitor againsthuman 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzymewith anIC50of 3.0 nM[1]. | ||||||||||||||||
IC50& Target | IC50: 3.0 nM (11β-HSD1)[1] | ||||||||||||||||
体外研究 (In Vitro) | 11β-HSD1 inhibition may be useful in the treatment of type II diabetes and other potential clinical utilities such as atheroprotection and cognitive protection. BMS-816336 (6n-2) inhibits 11β-HSD1 enzyme in HEK and 3T3L1 cells with IC50s of 37.3 and 28.6 nM, respectively[1]. | ||||||||||||||||
体内研究 (In Vivo) | BMS-816336 represents a potential new treatment for type 2 diabetes, metabolic syndrome, and other human diseases modulated by glucocorticoid control. BMS-816336 (6n-2) exhibits a robust acute pharmacodynamic effect in cynomolgus monkeys (ED50=0.12 mg/kg) and in DIO mice (1, 3, 10, 30, 100 mg/kg, 120 mintues). It is orally bioavailable (%F ranges from 20 to 72% in preclinical species) and has a predicted pharmacokinetic profile of a high peak to trough ratio and short half-life in humans[1].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 341.44 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C21H27NO3 | ||||||||||||||||
CAS 号 | 1009583-20-3 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 300 mg/mL(878.63 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |